CClinicalTrials.gg
CompletedNCT02906540Updated Mar 4, 2020

Transpubic Symphysis Reset for Treatment of Low Back Pain

An interventional study of Transpubic symphysis reset therapy group and Physiotherapy group in Low Back Pain, sponsored by Shengjing Hospital. Completed. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-03-04.

Sponsored by Shengjing Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

To verify the efficacy of transpubic symphysis reset therapy for low back pain, and provide support for the clinical application of this treatment.

Read the detailed description

Low back pain is a common clinical affliction involving the back muscles, nerves, and bones. This condition mainly manifests as limited lumbar mobility, decreased back muscle strength and endurance, and disordered as well as asymmetrical movement of lower back muscles. Although these symptoms can severely impact quality of life and work, most patients report no precise origin of the condition. Low back pain may be associated with mechanical musculoskeletal damage, inflammation, cancer, and infection. More than 80% of adults experience low back pain at some point during their lifespan, although most patients are between 40-80 years old. As many countries have an aging population, the incidence of low back pain is increasing globally. Most patients suffer recurrent low back pain, which becomes more and more serious with each manifestation.

Patients with nonspecific low back pain often choose conservative treatments, such as physiotherapy. Compared with surgery and drug therapy, physiotherapy is advantageous as a treatment associated with low trauma, high comfort, few side effects, and low cost. Previous studies have confirmed that treatment with ultrashort waves can improve blood and lymph circulation in diseased areas and enhance the phagocytosis of macrophages and leukocytes, as well as having an anti-inflammatory effect, making it effective in the treatment of low back pain. Additionally, thermotherapy can directly expand the microvascular network of external annulus fibrosus, increase vascular permeability, promote venous return of partial metabolic waste, increase analgesic substance endorphin levels in vivo, suppress the generation of pathological excitatory foci in the brain, and accelerate the self-repair of injured cells, thus improving low back pain.

Chinese traditional massage is also a common clinical therapy. The application of pressure to the waist, hip, and lower limb on the affected side of the body can improve local blood circulation, promote the absorption of inflammatory exudates, reduce muscle tension, loosens abdominal adhesion, and mitigate muscle spasms to restore a normal anatomical position. Indeed, the efficacy of massage in the treatment of low back pain has been confirmed, according to five reports addressing manipulation for treating low back pain in Science Citation Index and four separate trials regarding such manipulation listed in ClinicalTrials.gov.

Transpubic symphysis reset is a massage therapy for treatment of low back pain. Although the efficacy of this treatment has been observed in the clinic, few studies have reported on the efficacy of transpubic symphysis reset in mitigating low back pain.

Data collection, management, analysis, and open access Data collection Two physicians, who will not participate in the experimental treatment or evaluation, will collect all patient data. The investigators will use the double data entry strategy. The data will be summarized and numbered by the research manager. A database will be established using Excel software. For questionable data, the data manager will present the data query table to the investigator for review and response. The researcher will answer the questions and return the table as soon as possible. The data manager will modify and check the data according to the researcher's answer. If necessary, the data manager can resubmit a question sheet.

Data management After blind review and database confirmation, the researcher in charge, sponsor, and statisticians will lock the database. The locked database will not be altered and will be preserved, along with the original records, by Shengjing Hospital, China Medical University, China.

Data analysis All data will be statistically analyzed by professional statisticians. The results of these statistical analyses will be reported to a researcher and used to prepare the research report. An independent data monitoring committee will be responsible for data monitoring and management throughout the entire trial to ensure scientific accuracy, stringency, authenticity, and integrity.

Open access Published data will be available at www.figshare.com.

Statistical analysis All data will be statistically analyzed using the SPSS 17.0 statistical software package in line with the intention-to-treat principle. Data will be expressed as mean ± SD. Measurement data will be analyzed with an analysis of variance for independent samples. Normally distributed data will be analyzed using group t-tests. Non-normally distributed data will be compared using the Wilcoxon test. A value of P \< 0.05 will be considered statistically significant.

Confidentiality Patient information, including name, identity card number, address, and telephone number, will be encrypted in accordance with relevant Chinese laws and regulations. The findings will be published for scientific purposes without revealing any patient identities, except as required by law. Encoded information will be stored properly in Shengjing Hospital of China Medical University. To ensure that the research is in accordance with the applicable laws and regulations, relevant national authorities and the Ethics Committee of Shengjing Hospital of China Medical University will review patient records.

02

Conditions studied

  • Low Back Pain
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 100 is above the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Shengjing Hospital is the lead sponsor of 124 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • No abnormalities of the lumbar spine and no intervertebral disc slipping or mild protrusion revealed via CT scans or MRI
  • Pain in the lumbosacral region
  • Pain in the unilateral lower back, including the buttocks, inguinal region, and perineal region
  • Patient is unable to sit for a long duration
  • Varying degrees of crooked hip and claudication
  • A history of chronic fatigue disease involving a lumbar sprain, a fall injury affecting the buttocks, or prolonged sitting
  • Tenderness of sacroiliac joint on the affected side
  • Course of disease between 1 day and 6 months
  • Age between 18 and 75 years old, any gender
  • Provision of informed consent regarding the trial procedure

Exclusion criteria

Exclusion Criteria:

  • Sciatic nerve radiating pain caused by lumbar disc herniation
  • Lumbar spinal stenosis combined with intermittent claudication
  • Edema and necrosis produced by lumbar spinal cord compression revealed by MRI
  • Clear spinal deformity
  • Low back pain induced by cancer and associated inflammation
  • Hip malformation and bone disease
  • Coagulopathy
  • Ongoing participation in physiotherapy and massage therapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Transpubic symphysis reset therapy group

    Transpubic symphysis reset therapy will be conducted once a day for 7 consecutive days.

    Procedure: Transpubic symphysis reset therapy group

  • Experimental
    Physiotherapy group

    Physiotherapy and a sham reset treatment will be performed once a day for 7 consecutive days.

    Procedure: Physiotherapy group

Interventions

  • ProcedureTranspubic symphysis reset therapy group

    The patients in the treatment group will undergo daily transpubic symphysis reset therapy for 7 consecutive days.

  • ProcedurePhysiotherapy group

    The patients in the control group will undergo physiotherapy and a sham treatment.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale pain scores

    To use the Visual Analog Scale for pain to evaluate the severity of low back pain. The scale consists of a 10-cm line with 0 on one end, representing no pain, and 10 on the other, representing the worst pain ever experienced. The patient indicates their level of pain by placing a mark somewhere on the scale, between 0 and 10

    Time frame: 14 days after treatment

Secondary outcomes

  1. Changes of Oswestry Disability Index

    To assess the degree of impairment of limb function induced by low back pain.

    Time frame: 1, 7, and 14 days, and 1 month after treatment

  2. Changes of hip muscle strength

    To be measured using a Biodex isokinetic muscle testing machine (Biodex, Germany).

    Time frame: 1 day before treatment, 1, 7, 14 days, and 1 month after treatment

  3. Changes of joint motion

    To be measured using a Biodex isokinetic muscle testing machine (Biodex, Germany).

    Time frame: 1 day before treatment, 1, 7, 14 days, and 1 month after treatment

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02906540
Lead sponsor
Shengjing Hospital
Responsible party
Hongliang Liu (Attending Physician, Shengjing Hospital) — Principal investigator
First posted
Sep 20, 2016
Start date
Sep 1, 2016
Primary completion
Mar 1, 2017
Completion
Sep 30, 2018
Last update
Mar 4, 2020

Study contacts

Hongliang Liu, Ph.D
principal investigator · Shengjing Hospital Of China Medical University,China

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion